This site is intended for healthcare professionals
Inhaled Respiratory Therapies
Respiratory Care
Declaration of sponsorship Novartis Pharma AG

ERS 2020 Interviews

Declaration of sponsorship Novartis Pharma AG
Read time: 50 mins
Last updated:25th Nov 2020
Published:25th Nov 2020

At the virtual European Respiratory Society International Congress 2020 (ERS 2020) a wide range of fascinating sessions explored new therapies, environmentilism and digital innovations.

Watch our recent interviews below, with Professor Christer Janson and Professor David Price, to get an overview into these thought-provoking areas and learn more about new inhaled combination therapies, the environmental impact of metered-dose inhalers and cutting-edge digital innovations that are revolutionising personalised medicine.

What are the most recent advances to improve asthma management?

Discover the most recent advances to improve asthma management, including new inhaled combination therapies for uncontrolled asthma, how inhaler devices could address patient challenges as well as the impact of the the COVID-19 pandemic and flu season.

What are the environmental concerns of inhaled medication?

Gain insight into the impact of the global warming potential of metered dose inhalers (MDI) compared to dry power inhalers (DPI), the impact of hydrofluorocarbon (HFC) propellants and the trade-offs between effective delivery of medication and the environmental impact.

The unmet needs and digital innovations of asthma management

Get to know the unmet needs and challenges of asthma management and how digital innovations, such as online apps smart inhaler monitoring devices, and portable spirometry can help solve these issues.

The future of mHealth

Explore how mHealth applications may be useful in the future of asthma management, the current studies evaluating their impact on adherence and outcomes and the challenges that must be overcome.

Asthma management and digital innovations during the COVID-19 pandemic

Examine how coronavirus disease 2019 (COVID-19) has transformed the management of asthma and find out about digital innovations that are here to stay following the pandemic, including remote testing and smart inhaler technologies.

What is the role of telemedicine in asthma management?

Learn about the role of telemedicine in asthma management and discover how telemedicine can empower patients and improve efficiency for physcians. Also find out about the challenges in telemedicine that still need to be solved.

Smart inhaler monitoring devices and connected digital health ecosystems

Take a look at the emerging field of smart inhaler monitoring devices and learn about the information they collect, their benefits and how they may evolve in the future. Also gain an overview of the key elements to developing a digital health ecosystem in respiratory care.

The future of asthma management

Explore the future of asthma management from new approaches to treating patients and enhancing data collection to help better manage patients.

Meet Professor Christer Janson

Meet Christer Janson, Professor of Respiratory Medicine at Uppsala University, Sweden, and hear about his expertise in asthma, chronic obstructive pulmonary disease (COPD) and allergic diseases.

Meet Professor David Price

Meet David Price, Professor of Primary Care Respiratory Medicine at the University of Aberdeen, United Kingdom, and hear about his extensive work in real-life respiratory research.

Highlights from ERS 2020

Hear about Professor Price’s personal highlights from ERS 2020 this year such as early intervention in chronic obstructive pulmonary disease (COPD) and using technology to differentiate and diagnose asthma and COPD.